ArticleBioengineered2021

Identifying the Prognostic Risk Factors of Synaptojanin 2 and Its Underlying Perturbations Pathways in Hepatocellular Carcinoma.

Rui Zhang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.